MULTIMODAL WEARABLE
PHYSIOLOGICAL DIGITAL TWIN
PREDICTIVE INTELLIGENCE
MONITORING
LIMITATIONS
Healthcare Often Sees Deterioration Too Late
Health information is often divided across separate devices, symptoms, medication records and clinical systems. General thresholds may also overlook changes that are significant for a particular individual.
As a result, deterioration may become apparent only after symptoms have worsened or an urgent event has occurred.
One Platform. Multiple Care Pathways.
MediQAI’s proposed architecture is designed to support multiple clinical and safety pathways through patient-specific monitoring, longitudinal intelligence and clinician-directed escalation.
Older and Vulnerable People
Proposed fall and no-motion awareness, location support, geofencing, SOS communication and clinician-directed escalation.
Occupational Health
Predictive intelligence identifies meaningful changes against the individual’s evolving baseline and supports earlier clinical review by the doctor.
Cardiovascular Monitoring
Continuous rhythm surveillance and on-demand six-lead ECG designed to support earlier review of meaningful cardiac changes.
CONNECT
Building a Credible Pathway to Clinical Use
MediQAI is progressing through prototype development, engineering definition, quality and regulatory planning, and preparation for controlled clinical validation with appropriate partners.
PATENT-PENDING ARCHITECTURE
PROTOTYPE STAGE
VALIDATION REQUIRED
PARTNERSHIP-LED DEVELOPMENT
From Continuous Signals to Supported Action
MediQAI’s proposed architecture is designed to transform fragmented health information into a more connected, patient-specific picture that can support earlier clinical review.
The proposed wearable captures multimodal physiological, activity, location and safety information.
The proposed wearable captures multimodal physiological, activity, location and safety information.
Predictive intelligence evaluates changes against the individual's evolving baseline and longitudinal patterns.
Relevant evidence is presented for authorised clinical review and clinician-directed escalation if required.